JCM
GILD icon

Jacobi Capital Management’s Gilead Sciences GILD Stock Holding History

Jacobi Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Buy
23,498
+321
+1% +$45K 0.18% 109
2025
Q4 		$2.84M Sell
23,177
-2
-0% -$243 0.16% 115
2025
Q3 		$2.57M Buy
23,179
+46
+0.2% +$5.23K 0.16% 130
2025
Q2 		$2.56M Sell
23,133
-13
-0.1% -$1.38K 0.17% 121
2025
Q1 		$2.59M Sell
23,146
-3,924
-14% -$405K 0.19% 110
2024
Q4 		$2.5M Sell
27,070
-42
-0.2% -$3.78K 0.19% 109
2024
Q3 		$2.27M Buy
27,112
+8,246
+44% +$629K 0.17% 122
2024
Q2 		$1.29M Buy
18,866
+1,802
+11% +$120K 0.11% 173
2024
Q1 		$1.25M Buy
17,064
+3
+0% +$231 0.12% 169
2023
Q4 		$1.38M Buy
17,061
+98
+0.6% +$7.63K 0.14% 137
2023
Q3 		$1.27M Sell
16,963
-899
-5% -$69.1K 0.14% 137
2023
Q2 		$1.38M Sell
17,862
-1,601
-8% -$128K 0.15% 131
2023
Q1 		$1.61M Sell
19,463
-250
-1% -$20.7K 0.19% 107
2022
Q4 		$1.69M Sell
19,713
-681
-3% -$53.9K 0.21% 97
2022
Q3 		$1.26M Buy
20,394
+289
+1% +$18.2K 0.17% 123
2022
Q2 		$1.24M Buy
20,105
+1,439
+8% +$89.1K 0.17% 126
2022
Q1 		$1.11M Buy
18,666
+2,321
+14% +$148K 0.13% 153
2021
Q4 		$1.19M Buy
16,345
+1,173
+8% +$80.8K 0.14% 141
2021
Q3 		$1.06M Sell
15,172
-270
-2% -$19K 0.13% 136
2021
Q2 		$1.06M Sell
15,442
-75
-0.5% -$5.01K 0.14% 129
2021
Q1 		$1M Buy
15,517
+112
+0.7% +$7.22K 0.15% 130
2020
Q4 		$972K Buy
15,405
+2,145
+16% +$129K 0.15% 122
2020
Q3 		$818K Buy
13,260
+1,189
+10% +$82.5K 0.14% 124
2020
Q2 		$924K Buy
12,071
+123
+1% +$9.43K 0.17% 104
2020
Q1 		$937K Sell
11,948
-96
-0.8% -$6.63K 0.2% 92
2019
Q4 		$769K Buy
12,044
+297
+3% +$19.3K 0.14% 137
2019
Q3 		$763K Buy
11,747
+369
+3% +$24.1K 0.15% 127
2019
Q2 		$768K Buy
11,378
+9,530
+516% +$627K 0.16% 124
2019
Q1 		$120K Sell
1,848
-449
-20% -$29.8K 0.03% 292
2018
Q4 		$144K Sell
2,297
-719
-24% -$50.3K 0.04% 260
2018
Q3 		$233K Buy
3,016
+418
+16% +$31.6K 0.06% 199
2018
Q2 		$184K Buy
2,598
+583
+29% +$41.2K 0.05% 219
2018
Q1 		$147K Buy
2,015
+434
+27% +$34.5K 0.04% 236
2017
Q4 		$118K Buy
1,581
+943
+148% +$71.6K 0.04% 235
2017
Q3 		$52K Buy
638
+68
+12% +$5.2K 0.02% 335
2017
Q2 		$40K Buy
570
+117
+26% +$7.79K 0.02% 340
2017
Q1 		$30K Buy
453
+2
+0.4% +$141 0.02% 302
2016
Q4 		$33K Sell
451
-125
-22% -$9.29K 0.02% 266
2016
Q3 		$45K Buy
576
+2
+0.3% +$162 0.02% 249
2016
Q2 		$49K Buy
+574
New +$50.9K 0.02% 223

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jacobi Capital Management's GILD Position: Q1 2026 in Review

Jacobi Capital Management increased its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, buying an estimated $45K and bringing the position to 23,498 shares worth $3.27M. The position accounts for 0.18% of the portfolio, ranked #109.

Jacobi Capital Management first reported a position in GILD in Q2 2016 and has held it in 40 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jacobi Capital Management held 23,498 shares of Gilead Sciences worth $3.27M as of Q1 2026.
  • Jacobi Capital Management bought 321 Gilead Sciences shares in Q1 2026, an estimated $45K.
  • Gilead Sciences made up 0.18% of Jacobi Capital Management's portfolio in Q1 2026, its #109 holding.
  • Jacobi Capital Management first reported a position in Gilead Sciences in Q2 2016 and has held it in 40 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.